Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-mFBG PET Imaging in Lewy Body Diseases
NCT07176286Phase 2Recruiting
- Sponsor
- Innervate Radiopharmaceuticals
- Start
- Apr 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florbenguane F-18 in Parkinson's disease (PD), Lewy body dementia (LBD), sponsored by Innervate Radiopharmaceuticals. Started Apr 2026; status: recruiting.
02
Drugs
florbenguane F-18
03
Conditions
Parkinson's disease (PD)Lewy body dementia (LBD)
Beyond the preview
Go deeper on NCT07176286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07176286.